JPM vs PMM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PMM presents a stable Piotroski F-Score of 6/9, but this fundamental health is undermined by severe valuation and sustainability concerns. The stock is currently trading at $6.16, which is significantly above its Intrinsic Value of $1.26 and its Graham Number of $5.21. Most critically, the dividend payout ratio of 167.67% is unsustainable, indicating the trust is returning more capital to shareholders than it is earning. Combined with stagnant revenue growth (-0.20%) and a completely bearish technical trend (0/100), the current price appears unsupported by data.
Compare Another Pair
Related Comparisons
JPM vs PMM: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Putnam Managed Municipal Income Trust (PMM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.